Navigation Links
ARVO Foundation and Merck to provide prestigious global ophthalmic research award
Date:11/3/2008

Rockville, MD -- The ARVO Foundation for Eye Research (AFER) and Merck & Co., Inc. are pleased to announce a series of awards that honor young scientists throughout the world for their innovative contributions to ophthalmology research. Each award cycle is worth a total of $70,000 in grants.

The ARVO-AFER/Merck Innovative Ophthalmology Research Award (IORA), formerly Merck's Chibret Award, created in honor of French ophthalmologist Dr. Paul Chibret, is designed to encourage researchers to undertake investigative work in critical areas of ophthalmology. Since its initiation in 1982, more than 50 scientists age 45 or younger have received the award.

Merck, a leader in ophthalmology for over 50 years, will sponsor the ARVO-AFER/Merck Innovative Ophthalmology Research Award through a donation to AFER. The award will be presented biennially beginning in 2009 (for submissions received in 2008). In addition to monetary prizes, the awards cover recipients' travel expenses and registration fees for the ARVO Annual Meeting, which takes place in Fort Lauderdale, FL, each April/May.

"Merck is proud to support the ARVO Foundation for Eye Research by continuing to sponsor this global award that recognizes promising scientists and their pioneering work in the field of ophthalmology," said Anastasia Daifotis, MD, Vice President, Global Medical Affairs, Merck & Co., Inc. "We hope that AFER's global efforts to encourage innovation and promote support for eye and vision research will continue to inspire even more young scientists."

"AFER is looking forward to opening more doors for young researchers through the Innovative Ophthalmology Research Award," added Gary Abrams, MD, Chairman of AFER's Board of Governors. "We welcome Merck's continuing support and commitment to rigorous, inventive ophthalmic research."

2009 ARVO-AFER/Merck IORA:

The application period for the 2009 award ended in June 2008. AFER, with assistance from ARVO, will conduct the review and selection process of eligible submissions. AFER will announce recipients of the 2009 awards in conjunction with the ARVO 2009 Annual Meeting (May 3-7). There will be first and second place award grants for each of two categories (glaucoma and back-of-the-eye diseases). The four grants total $70,000.

2010 and beyond:

Beginning in 2010, investigators at the MD, PhD or equivalent doctoral level degree from any part of the world will be invited to apply for the 2011 awards. ARVO will select two research topics and award six grants totaling $70,000.


'/>"/>

Contact: Joanne Olson
jolson@arvo.org
240-221-2923
Association for Research in Vision and Ophthalmology
Source:Eurekalert

Related medicine news :

1. National Patient Safety Foundation Partners with Vocera Communications
2. R. P. Simmons Family Foundation Pledges $2 Million for New Childrens Hospital of Pittsburgh of UPMC Campus
3. Patient Advocate Foundation Launches Program to Help Uninsured Virginians with Chronic, Debilitating and Life-Threatening Illness Access Quality Healthcare
4. AIDS Healthcare Foundation Applauds City Commissioners Support of Diversity, Urges Call for Mayors Resignation
5. National Osteoporosis Foundation Teams Up With Ladies Home Journal Magazine to Launch a 10-city Mall Walk Tour
6. Judge Rules That Florida Disease Management Program Serving 8,000 HIV/AIDS Patients Should Be Re-bid, Says AIDS Healthcare Foundation
7. The Tug McGraw Foundation Announces 2007 Fundraising Gala
8. The Arthur M. Blank Family Foundation Pushes for Pre-K Expansion in Georgia
9. Cipla, Tell the Truth; AIDS Healthcare Foundation Launches New Ad Campaign
10. Survey From The Partnership and MetLife Foundation Reveals Important Role Todays Grandparents Play in Teens Lives
11. Exceptional Childrens Foundation Merger with Kayne Eras Center Creates One of States Most Comprehensive Nonprofits Serving the Disabled
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... Seattle, Washington (PRWEB) , ... April 24, 2017 , ... ... T-Fal OptiGrill, Oxiclean, Space Bag, Sonicare Toothbrush, Juiceman Juicer, and the George Foreman Grill ... than perhaps any other marketer in the last 25 years. , Now, due to ...
(Date:4/24/2017)... ... April 24, 2017 , ... The world-class designers ... to bring their novel lifesaving device for the everyday use of parents worldwide. ... specially designed to read a child’s vital signs, and detect unusual symptoms or ...
(Date:4/24/2017)... ... April 24, 2017 , ... According to ... deaths now claim the lives of 62 Americans each day.(1) Yet since 2011, ... manufacturers, distributors, pharmacies and prescribers by more than half.(2) Novus Medical Detox ...
(Date:4/24/2017)... ... April 24, 2017 , ... Pitavastatin, ... HIV because it is not known to have significant interactions with antiretroviral therapy ... both lower cholesterol levels and dampen inflammation in the bloodstream. , While lowering ...
(Date:4/24/2017)... FOREST KNOLLS, Calif. (PRWEB) , ... April 24, 2017 , ... ... and health topics, but she has not found any of them to be very ... weekly actions to slowly and easily make changes in their health. It prompted her ...
Breaking Medicine News(10 mins):
(Date:4/21/2017)... , April 21, 2017 Halo Labs ... throughput biopharmaceutical particle analysis system called the Horizon at ... May 1st. The new system analyzes sub visible particulate ... time rapid particle screening as early as candidate selection ... with leading biopharma contract research organization Elion Labs ...
(Date:4/20/2017)... , April 20, 2017  RXi Pharmaceuticals Corporation ... therapeutics that address significant unmet medical needs, today ... the Company,s consumer product development program, based on ... Society for Investigative Dermatology (SID) 76 th ... and promote the sciences relevant to skin health ...
(Date:4/20/2017)... , April 20, 2017 Research and ... Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, ... report to their offering. ... The global pharmacogenomics market was valued at US$ 7,167.6 Mn ... by 2024, expanding at a CAGR of 5.6% from 2016 ...
Breaking Medicine Technology: